CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total		Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning balance (in shares) at Jun. 25, 2023			1,332,966
Beginning balance at Jun. 25, 2023	$ 8,210,172		$ 1,333	$ 7,806,749	$ (21,529,300)	$ (100,706)	$ 22,032,096
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)			4,820
Issuance of common stock	12,757		$ 5	$ 12,752
Purchase of treasury stock (in shares)			(31,929)
Purchase of treasury stock	$ (2,460,634)		$ (32)		$ (2,460,602)
Reissuance of treasury stock			$ 1,504
Reissuance of treasury stock (in shares)	53,081		1	46,615	6,465
Equity-based compensation expense	$ 213,966			$ 213,966
Net income	2,807,490						2,807,490
Other comprehensive (loss) income	(27,082)					(27,082)
Cash dividends declared	(787,649)						(787,649)
Ending balance (in shares) at Mar. 31, 2024			1,307,361
Ending balance at Mar. 31, 2024	8,022,101		$ 1,307	8,080,082	$ (23,983,437)	(127,788)	24,051,937
Beginning balance (in shares) at Dec. 24, 2023			1,312,782
Beginning balance at Dec. 24, 2023	8,222,478		$ 1,313	7,994,997	(23,003,286)	(117,694)	23,347,148
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)			4,094
Issuance of common stock	8,235		$ 4	8,231
Purchase of treasury stock (in shares)			(9,515)
Purchase of treasury stock	(980,161)		$ (10)		(980,151)
Equity-based compensation expense	76,854			76,854
Net income	965,826						965,826
Other comprehensive (loss) income	(10,094)					(10,094)
Cash dividends declared	(261,037)						(261,037)
Ending balance (in shares) at Mar. 31, 2024			1,307,361
Ending balance at Mar. 31, 2024	$ 8,022,101		$ 1,307	8,080,082	(23,983,437)	(127,788)	24,051,937
Beginning balance (in shares) at Jun. 30, 2024	1,303,769		1,303,769
Beginning balance at Jun. 30, 2024	$ 8,539,454	[1]	$ 1,304	8,223,046	(24,365,783)	(130,428)	24,811,315
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)			3,990
Issuance of common stock	1,756		$ 4	1,752
Purchase of treasury stock (in shares)			(25,964)
Purchase of treasury stock	(2,095,540)		$ (26)		(2,095,514)
Reissuance of treasury stock	60,557		$ 1	55,124	5,432
Reissuance of treasury stock (in shares)			1,162
Equity-based compensation expense	249,085			249,085
Net income	3,638,129						3,638,129
Other comprehensive (loss) income	6,517					6,517
Cash dividends declared	$ (888,853)						(888,853)
Ending balance (in shares) at Mar. 30, 2025	1,282,957		1,282,957
Ending balance at Mar. 30, 2025	$ 9,511,105		$ 1,283	8,529,007	(26,455,865)	(123,911)	27,560,591
Beginning balance (in shares) at Dec. 29, 2024			1,284,956
Beginning balance at Dec. 29, 2024	8,808,026		$ 1,285	8,439,903	(26,024,098)	(134,085)	26,525,021
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)			3,558
Issuance of common stock	1,993		$ 4	1,989
Purchase of treasury stock (in shares)			(5,557)
Purchase of treasury stock	(431,773)		$ (6)		(431,767)
Equity-based compensation expense	87,115			87,115
Net income	1,330,667						1,330,667
Other comprehensive (loss) income	10,174					10,174
Cash dividends declared	$ (295,097)						(295,097)
Ending balance (in shares) at Mar. 30, 2025	1,282,957		1,282,957
Ending balance at Mar. 30, 2025	$ 9,511,105		$ 1,283	$ 8,529,007	$ (26,455,865)	$ (123,911)	$ 27,560,591

[1] Derived from audited financial statements